Red Light Therapy for Fertility: Evidence & Protocols
TL;DR
-Red light therapy has documented biological mechanisms that are directly relevant to fertility. Eggs contain more mitochondria than any other cell in the human body, and mitochondrial ATP production is the primary driver of egg quality and embryo viability. Photobiomodulation's core effect is mitochondrial activation, making it mechanistically well-suited to fertility applications.
-A 2024 prospective case series published in the Journal of Clinical Medicine documented improved fertility outcomes and healthy live births in all three subjects with unexplained age-related infertility, including women aged 40 to 43 with histories of multiple miscarriages, molar pregnancy, failed IVF cycles, and non-viable embryos. All three subjects delivered healthy babies following multiwavelength PBM treatment.
-Earlier large-scale data from Danish and Japanese fertility clinics reported pregnancy rates of 22 to 66% in women with severe infertility histories following PBM treatment, with the Danish study documenting approximately 65% of around 400 treated women achieving pregnancy and live birth.
-Near-infrared wavelengths at 810 to 940nm are most relevant for fertility given the depth of pelvic reproductive organs. Red light at 660nm supports surface circulation, endometrial lining, and hormonal balance. Multiwavelength protocols using both red and NIR are used in all the key fertility studies.
-Always consult a fertility specialist or reproductive endocrinologist before starting red light therapy as a fertility support strategy, particularly during an active IVF cycle.
For many Australians navigating fertility challenges, the intersection of emerging wellness therapies and assisted reproductive technology raises important questions. Red light therapy is increasingly discussed in fertility communities, with growing clinical evidence supporting its biological rationale for improving egg quality, endometrial receptivity, and overall reproductive outcomes. This article works through what the research actually shows, explains the mechanisms in accessible terms, and provides practical guidance for people considering red light therapy as part of their fertility journey.
Why Eggs Respond to Red Light Therapy
The biological connection between red light therapy and fertility starts with a striking fact: egg cells contain more mitochondria than any other cell in the human body. As documented in a study by Babayev et al. (2015), this extraordinary mitochondrial density exists because the egg needs enormous quantities of ATP energy to complete meiosis (the cell division that produces a viable egg), support fertilisation, and fuel the first critical days of embryonic development before the embryo develops its own energy production capacity.
As women age, mitochondrial function in eggs declines. Mitochondrial DNA mutations accumulate, ATP production decreases, and the egg's capacity to support normal chromosomal segregation during meiosis is compromised. This is the primary driver of age-related fertility decline, explaining why IVF success rates drop so significantly from the mid-30s onwards: fewer eggs have sufficient mitochondrial energy to produce viable, chromosomally normal embryos.
Red and near-infrared light therapy's primary mechanism is the activation of cytochrome c oxidase in the mitochondrial respiratory chain, increasing ATP synthesis, reducing oxidative stress, and supporting mitochondrial function. The 2024 case series by Phypers, Berisha-Muharremi, and Hanna published in the Journal of Clinical Medicine directly addresses this connection, noting that PBM's upstream and downstream biological chain of events regenerates tissue, improves angiogenesis, and increases mitochondrial energy by increasing ATP synthesis in the eggs.
The Clinical Evidence
The 2024 London Case Series (Phypers et al.)
The most detailed and recent clinical evidence for PBM in female fertility is the 2024 prospective case series by Phypers et al. published in the Journal of Clinical Medicine, conducted at the Laser Medicine Centre at 134 Harley Street, London. The study enrolled three women aged 40 to 43 with unexplained age-related infertility, all of whom had failed to conceive naturally beyond two years, with histories including multiple miscarriages, molar pregnancy, failed IVF cycles with non-viable embryos, and failure to implant chromosomally tested euploid embryos.
The study used multiwavelength red and near-infrared PBM with wavelengths of 660nm, 810nm, 850nm, 880nm, and 940nm (LED device) and 660nm, 800nm, 905nm, and 970nm (laser device), applied transdermally at treatment points above the ovaries and uterus, the lower back and sacrum, the cervical spine, and lymph nodes. Treatment was aligned with IVF cycles or natural conception attempts, with sessions ranging from weekly to twice-weekly over periods of several weeks to several months.
In every case, fertility outcomes improved. All three subjects achieved full-term pregnancies and delivered healthy babies. Subject one, aged 41 at conception, delivered after IVF following a history of three miscarriages and a molar pregnancy. Subject two, aged 40, delivered after a fifth IVF cycle having previously had four unsuccessful cycles. Subject three, aged 42, achieved spontaneous natural conception and delivered a healthy baby, having previously failed multiple IVF cycles including all embryos testing as chromosomally abnormal.
Importantly, the researchers noted that subject three's most successful egg retrieval following PBM produced seven fertilised embryos, six of which developed to day five blastocysts, described as the most successful IVF cycle she had experienced, even though all embryos tested as aneuploid. The subsequent natural conception following further PBM sessions suggests the therapy's effects extended beyond the IVF cycle itself to improve the broader reproductive environment.
The Grinsted Danish Clinic Data (2022)
An earlier large-scale dataset from Danish fertility clinics was reported by Grinsted et al. in 2022, documenting outcomes in approximately 400 women aged 34 to 50 years old with a diagnosis of infertility who had previously tried dietary changes, exercise, hormonal treatments, IUI, IVF, and ICSI without success. Following PBM treatment of 23 minutes per session delivering 20,000 joules (15,000 J near-infrared at 808nm and 5,000 J red at 660nm) placed 1 to 2cm above the skin over a 500 cm² treatment area, approximately 65% of treated women became pregnant and had healthy live births. The researchers concluded that PBM could be a viable choice as a natural, non-invasive addition to other methods of assisted reproductive technology.
The Ohshiro Japanese Clinic Data (2012)
The Japanese fertility clinic data published by Ohshiro et al. in 2012 evaluated near-infrared PBM at 830nm applied to the neck and upper vasculature of 701 severely infertile women between 1996 and 2012, with an average infertility history of 9.13 years and unsuccessful ART. Following an average of 21 PBM sessions, 22.3% of treated women achieved pregnancy, resulting in 79 live births (50.1% of clinical pregnancies). The researchers proposed the Proximal Priority Theory, based on the finding that treating the cervical spine and upper vasculature had downstream effects on reproductive hormone regulation through the hypothalamus and pituitary gland, the master hormonal regulators of the reproductive cycle.
How Red Light Therapy Supports Fertility: The Mechanisms
Egg Quality and Mitochondrial ATP Production
As outlined above, mitochondrial ATP production is the foundation of egg quality. PBM activates cytochrome c oxidase, the primary photoacceptor in the mitochondrial respiratory chain, increasing electron transport efficiency and ATP output. In the context of age-related infertility where mitochondrial DNA mutations compromise energy production in eggs, this direct mitochondrial activation addresses one of the root causes of poor egg quality and embryo non-viability.
Endometrial Receptivity and Blood Flow
Successful embryo implantation requires a well-vascularised endometrial lining with adequate thickness and receptivity. Red and near-infrared light's effects on nitric oxide production and vascular endothelial growth factor (VEGF) upregulation improve blood flow to the uterine lining, supporting endometrial development. A study by El Faham et al. (2018) postulated that applying PBM to the lower abdomen can improve the proliferative and functional capacity of endometrial cells of the inner lining of the uterus, which is directly relevant to embryo transfer success in IVF.
Oxidative Stress Reduction
Oxidative stress is a significant contributor to poor egg and embryo quality, with reactive oxygen species damaging egg cell membranes, mitochondrial DNA, and the meiotic spindle responsible for chromosomal segregation. Red and near-infrared light reduces ROS production and upregulates antioxidant pathways, creating a more favourable cellular environment for egg maturation and embryo development.
Hormonal Balance and the Proximal Priority Theory
The Ohshiro Proximal Priority Theory proposed that treating the cervical spine and neck vasculature with near-infrared light has downstream effects on the hypothalamus and anterior pituitary, which regulate the reproductive hormonal cascade including FSH, LH, oestrogen, and progesterone. This systemic hormonal regulation mechanism, distinct from the local ovarian and uterine effects, may contribute to improved menstrual cycle regularity and ovulatory function in women with hormonal contributions to infertility.
Gut Microbiome and Reproductive Health
A less commonly discussed mechanism noted in the Phypers et al. 2024 protocol is the inclusion of treatment points around the naval and upper digestive tract to support gut microbiome health. Research has established a connection between gut microbiome composition and genital tract microbiome, both of which influence implantation success. PBM's documented effects on gut microbiome health provide an additional systemic pathway through which fertility outcomes may be supported.
Male Fertility
The fertility evidence for red light therapy is not limited to female fertility. Red wavelengths at 630 to 670nm have been studied for sperm quality, with research documenting improvements in sperm motility, concentration, and reduced DNA fragmentation following irradiation. A 2021 review of photobiomodulation and male fertility found that red light irradiation at appropriate doses improved sperm motility and reduced oxidative damage to sperm DNA, with the anti-oxidative mechanisms of PBM directly relevant to the oxidative stress that is a common driver of poor sperm parameters.
For couples undergoing IVF where both egg and sperm quality are relevant to embryo viability, a combined approach addressing both partners is worth discussing with the treating fertility specialist.
Timing Red Light Therapy With Your Fertility Cycle
The timing of PBM sessions relative to the menstrual cycle and any IVF protocol matters. The Phypers et al. study used different protocols for different phases of treatment, and the Grinsted Danish data used a protocol starting on day one of menstruation with sessions across the first two weeks leading to ovulation. The following general framework is drawn from the available clinical protocols:
Pre-Conception and IVF Preparation (Weeks 1 to 12)
For women beginning PBM as a fertility support strategy, a preparation phase of two to three months before attempting conception or commencing an IVF cycle allows time for mitochondrial improvements in developing eggs to accumulate. Eggs take approximately 90 days to mature from early follicle stage to ovulation, meaning that PBM sessions during the three months before egg retrieval or natural conception attempts are working on the eggs that will be relevant to that cycle.
- Sessions: one to two per week
- Duration: 15 to 30 minutes per session
- Treatment areas: lower abdomen above ovaries and uterus, lower back and sacrum, cervical spine
During an IVF Stimulation Cycle
PBM sessions during the stimulation phase of an IVF cycle, from day one of menstruation through to egg retrieval, align with the approach used in the Phypers et al. case series and the Grinsted Danish data. Sessions two to three times per week during stimulation support the developing follicles and improving endometrial conditions for embryo transfer.
Pre-Transfer Phase
In the Phypers et al. protocol, additional PBM sessions were given in the week or two before embryo transfer, with treatment points focused on the uterine and lower abdominal area to support endometrial receptivity immediately before implantation.
Important: Stop Abdominal Treatment After Confirmed Pregnancy
Once pregnancy is confirmed, abdominal and pelvic PBM treatment should stop. As covered in our pregnancy blog, the consistent guidance is to avoid applying red light therapy directly over the abdomen during pregnancy. The Phypers et al. study demonstrates this clearly: when treating subject three during the first trimester to support mitochondrial energy, the protocol specifically avoided the abdominal area and instead applied PBM to the cervical spine, lymph nodes, and soles of the feet only.
StreamShop Devices for Fertility Support
For fertility applications, near-infrared wavelengths capable of penetrating to pelvic organ depth are the priority. The uterus and ovaries sit several centimetres below the abdominal surface, making deeper-penetrating wavelengths more relevant than surface red light alone.
Portable Red Light Therapy Pad with Near-Infrared
StreamShop's portable red light therapy pad with near-infrared delivers 660nm and 850nm wavelengths and is the most practical entry-level option for fertility use. Its flexible design can be strapped and fastened directly over the lower abdomen, allowing hands-free passive treatment in a seated or lying position. This makes it easy to complete daily sessions without holding a device in position, which is particularly practical for the consistent two to three sessions per week required in fertility protocols. The 850nm near-infrared wavelength penetrates to the pelvic tissue depth relevant to ovarian and uterine targets.
SS300 Pro and SS450 Pro Medical Grade Panels
StreamShop's SS300 Pro and SS450 Pro class IIa medical grade panels deliver 175.1 mW/cm² at 15cm across nine wavelengths including 660nm, 810nm, 830nm, 850nm, 940nm, and 1060nm. The multiwavelength configuration directly mirrors the wavelength range used in the Phypers et al. clinical protocols (660nm, 810nm, 850nm, 880nm, 940nm). The high irradiance ensures adequate photon delivery to deep pelvic tissue targets. For fertility applications, positioning the panel over the lower abdomen and lower back at 10 to 15cm during sessions of 15 to 20 minutes is the most applicable home use approach.
Class IIa Medical Grade Desktop Panel
StreamShop's class IIa medical grade desktop panel delivers 160 mW/cm² across the same nine wavelengths with per-wavelength dimming and 0 to 10,000 Hz pulse control. The pulse frequency range is relevant for fertility given that the Phypers et al. LED protocol used pulsed wave operation between 146 Hz and 5,000 Hz. For users wanting to replicate the pulsed protocol used in the clinical research, this device provides the most precise protocol control available.
Red Light Therapy Laser Mat with 1064nm
StreamShop's red light therapy laser mat with 1064nm combines six wavelengths including 660nm, 830nm, 850nm, 940nm, and 1064nm at 110 mW/cm² across a 1.8m x 80cm treatment surface. For whole-body systemic treatment that supports both reproductive organ targets and the cervical spine and lymphatic points used in the Ohshiro Proximal Priority protocol, the mat provides full-body coverage in a single session. This is particularly relevant for the pre-conception preparation phase where both local reproductive organ and systemic hormonal support are the treatment goals.
Important Considerations for Fertility Use
-Always consult a fertility specialist or reproductive endocrinologist before starting red light therapy as a fertility support strategy. PBM should be used alongside, not instead of, evidence-based fertility treatment.
-If you are undergoing IVF, discuss PBM timing with your fertility clinic before starting. The published protocols align PBM with specific phases of the IVF cycle and timing matters.
-Stop abdominal treatment immediately upon confirmed pregnancy. Follow the pregnancy blog guidance for any ongoing PBM use during the first trimester and beyond.
-The evidence base for PBM in fertility is promising but based primarily on case series and retrospective clinic data rather than large-scale randomised controlled trials. The biological plausibility is strong, but individual outcomes will vary.
-Male fertility applications should be discussed with a urologist or fertility specialist, particularly if sperm parameters are a contributing factor in the fertility assessment.
Frequently Asked Questions
Can Red Light Therapy Help With Fertility?
Research supports red light therapy as a biologically plausible and clinically promising complementary approach for fertility. The 2024 Phypers et al. case series documented improved fertility outcomes and healthy live births in all three subjects with unexplained age-related infertility. Earlier Danish and Japanese clinic data reported pregnancy rates of 22 to 66% in women with severe infertility histories following PBM treatment. The evidence base is growing but remains primarily in case series and retrospective data rather than large-scale RCTs.
Red Light Therapy and IVF: Can They Be Combined?
Yes, and this is how PBM has been used in most of the published fertility research. The Phypers et al. protocol applied PBM in the lead-up to egg retrieval, during stimulation cycles, and before embryo transfer. The Danish clinic data also used PBM alongside IVF. Sessions should be timed to align with the relevant phases of the IVF cycle, and the treating fertility specialist should be informed of PBM use.
Does Red Light Therapy Improve Egg Quality?
The evidence suggests PBM can support egg quality by improving mitochondrial ATP production in oocytes. Eggs contain more mitochondria than any other cell in the body, and age-related mitochondrial decline is the primary driver of reduced egg quality. PBM's mitochondrial activation mechanism directly addresses this. The improvement in embryo quality outcomes documented in the Phypers et al. study, including more blastocysts reaching day five in the most PBM-intensive cycles, is consistent with this mechanism.
How Long Does Red Light Therapy Take to Work for Fertility?
The preparation phase of two to three months before egg retrieval or conception attempts is the most evidence-aligned approach, because eggs take approximately 90 days to mature and PBM sessions during this window influence the eggs that will be relevant to that cycle. Most published fertility protocols use a minimum of four to twelve weeks of treatment before assessing outcomes, with more sessions generally producing better results in the available data.
What Wavelength Is Best for Fertility?
Near-infrared wavelengths at 810 to 940nm are most relevant for fertility applications given the depth of reproductive organs. Red light at 660nm supports endometrial circulation and surface tissue effects. All the key fertility research protocols used multiwavelength combinations of red and NIR, with the Phypers et al. study using five wavelengths from 660nm to 940nm. Devices that offer this multiwavelength range are most appropriate for fertility support.
Is Red Light Therapy Safe During IVF?
The published protocols apply PBM before and during stimulation phases and pre-transfer, with no adverse effects reported in any of the published fertility studies. The Phypers et al. study specifically noted that no adverse effects were observed across all treatment phases. However, abdominal PBM should stop once pregnancy is confirmed, and any use during an active IVF cycle should be discussed with the treating fertility specialist first.